maintrac
- maintrac -|-179-|-
-
Cancer diseases
-
Black skin cancer / Malignant melanoma
Basically the success of treatment in black skin cancer can be monitored through the number of circulating tumor cells in the blood.
-
Breast cancer / Mamma carcinoma
Both in adjuvant as well as in neoadjuvant therapy, maintrac® can help to monitor breast cancer therapy and make an optimization if required.
-
Colon cancer / Colon carcinoma
With maintrac® the effectiveness of chemotherapeutic agents can already be tested prior to the colon cancer treatment.
-
Lung cancer / Bronchial carcinoma
maintrac® is able to support the control of therapy success and helps choosing promising therapy strategies regarding the stage of disease and treatment.
-
Ovarian cancer / Ovarian carcinoma
With the possibility of testing various substances with maintrac®, the patient already gets to know the substance most likely to be effective against the CETCs even before starting chemotherapy.
-
Prostate cancer / Prostate carcinoma
In particular in the situation of watch-and-wait in prostate cancer, maintrac® can be applied for active surveillance.
-
Stomach cancer / Stomach carcinoma
After cancer therapy is successfully accomplished, the calculated course of cell counts of maintrac® can be an indication wheter stomach cancer stays in remission or is about to return.
-
Other types of cancer
maintrac® can also be applied for further tumor types, such as sarcoma, to monitor the therapy and/or characterize the therapy-relevant properties.
-
Black skin cancer / Malignant melanoma
-
Applications
-
Monitoring of therapy
Through the accompanying determination of cell counts with maintrac®, it is possible to optimize and personalize the treatment during the whole course of disease.
-
Testing of medications
With maintrac® it is possible to identify the drug which is likely to be most effective prior to the therapy.
-
Therapy-relevant characteristics
Certain substances (targeted tumor therapies) only prove useful if tumor cells exhibit the relevant properties.
-
Early detection of new tumor activity
An increase of circulating tumor cells (CETC / CTC) in the blood can be determined with maintrac® and may indicate new tumor activity.
-
Monitoring of therapy
-
Therapy situations
-
Neoadjuvant therapy
In neoadjuvant therapy, maintrac® can assess the effectiveness of treatment and draw attention to relapses at an early stage.
-
Adjuvant therapy
In addition to the monitoring of therapy success, maintrac® is able to identify medications which are most probable to be effective on the circulating tumor cells in the blood.
-
Metastatic situation
In the metastatic situation, the maintrac® cell courses should be interpreted individually due to various possibilities of interpretation.
-
Hormone Therapy / Maintenance Therapy
During hormone and maintenance therapy, maintrac® can also support the monitoring of cancer diseases as well as the decision making concering further therapies.
-
Watch-and-wait
During the „watch and wait“ approach, maintrac® can keep a close check on tumor activity.
-
Neoadjuvant therapy
- Order
-
Download
-
Download
On this page, you can find out about how to receive the lab request form for maintrac®; you will also be provided with information on how the blood samples should be send.
-
Information material
You can download our current information documents here. There you will learn about the applications of maintrac®.
-
Publications
Obtain an overview Verschaffen Sie sich einen Überblick zu den wichtigsten Studien und Publikationen der letzten Jahre. Bei Fragen zur Literatur wenden Sie sich gerne direkt an uns.
-
Download
- News
